Trinity Biotech PLC
TRIB- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000888721
No open-market purchases or sales by Trinity Biotech PLC insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $379.5K in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Trinity Biotech PLC as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- −2 vs. Q1 2022
- Shares held
- 7.29M
- −1.72M (−19.1%) vs. Q1 2022
- Total value
- $8.92M
- −$638.0K (−6.7%) vs. Q1 2022
- New holders
- 3
- 1 more added
- Sold out
- 5
- 7 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TRIB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $379.5K |
| Q1 2026 | 23 | $588.9K |
| Q4 2025 | 27 | $673.3K |
| Q3 2025 | 28 | $2.81M |
| Q2 2025 | 25 | $1.66M |
| Q1 2025 | 27 | $468.1K |
| Q4 2024 | 23 | $2.30M |
| Q3 2024 | 19 | $2.95M |
| Q2 2024 | 20 | $5.67M |
| Q1 2024 | 19 | $5.95M |
| Q4 2023 | 26 | $2.58M |
| Q3 2023 | 20 | $4.49M |
| Q2 2023 | 20 | $5.93M |
| Q1 2023 | 20 | $5.96M |
| Q4 2022 | 20 | $6.51M |
| Q3 2022 | 21 | $7.50M |
| Q2 2022 | 20 | $8.92M |
| Q1 2022 | 22 | $9.56M |
| Q4 2021 | 21 | $7.70M |
| Q3 2021 | 23 | $11.9M |
| Q2 2021 | 29 | $16.6M |
| Q1 2021 | 34 | $20.3M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Trinity Biotech PLC; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citigroup Inc | 4 | $0 | 0.00% | 00.0% | Unchanged |
| Atwood & Palmer Inc | 100 | $0 | 0.00% | 00.0% | Unchanged |
| US Bancorp | 972 | $1.00K | 0.00% | −65−6.3% | Reduced |
| Bank of America Corp | 1,204 | $1.00K | 0.00% | 00.0% | Unchanged |
| Rockefeller Capital Management L.P. | 944 | $1.00K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 992 | $1.00K | 0.00% | +992 | New |
| Susquehanna International Group, LLP | 10,598 | $13.0K | 0.00% | −5,080−32.4% | Reduced |
| Two Sigma Securities, LLC | 11,049 | $14.0K | 0.00% | +11,049 | New |
| Atria Wealth Solutions, Inc. | 24,700 | $30.0K | 0.00% | −800−3.1% | Reduced |
| State of New Jersey Common Pension Fund D | 27,062 | $33.0K | 0.00% | 00.0% | Unchanged |
| Wealthsource Partners, LLC | 30,200 | $37.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 46,983 | $57.0K | 0.00% | −60,873−56.4% | Reduced |
| LPL Financial LLC | 48,750 | $60.0K | 0.00% | −52,923−52.1% | Reduced |
| Envestnet Asset Management Inc | 98,067 | $120.0K | 0.00% | 00.0% | Unchanged |
| Aristides Capital LLC | 240,679 | $295.0K | 0.23% | +240,679 | New |
| Whitefort Capital Management, LP | 409,517 | $502.0K | 0.63% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 760,208 | $931.0K | 0.00% | −55,253−6.8% | Reduced |
| Renaissance Technologies LLC | 1,503,336 | $1.84M | 0.00% | +34,900+2.4% | Added |
| Hunter Associates Investment Management LLC | 1,808,533 | $2.20M | 0.54% | −603,583−25.0% | Reduced |
| Stonehill Capital Management LLC | 2,270,717 | $2.78M | 1.85% | 00.0% | Unchanged |
| Highbridge Capital Management LLC | 0 | $0 | 0.00% | −1,151,610−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −42,365−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −37,926−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −837−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −701−100.0% | Sold out |